These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8743280

  • 1. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
    Marabini R, Sirtori P, Chionna R, Barzizza L, Rubinacci A.
    J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodelling in postmenopausal women.
    Sirtori P, Sosio C, Resmini G, Rubinacci A.
    Pharmacol Res; 1996 Jun; 33(6):353-9. PubMed ID: 8971958
    [Abstract] [Full Text] [Related]

  • 6. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
    Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, Baylink DJ.
    Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown.
    Grazioli V, Casari E, Murone M, Bonini PA.
    J Chromatogr; 1993 May 19; 615(1):59-66. PubMed ID: 8340463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A, Branca F, Spadoni GL, Cianfarani S, Pasquino AM, Argirò G, Vitale S, Robins SP, Boscherini B.
    J Clin Endocrinol Metab; 1996 Oct 19; 81(10):3589-93. PubMed ID: 8855806
    [Abstract] [Full Text] [Related]

  • 13. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD.
    J Clin Endocrinol Metab; 1991 Feb 19; 72(2):367-73. PubMed ID: 1991806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.
    Chen JT, Hosoda K, Hasumi K, Ogata E, Shiraki M.
    J Bone Miner Res; 1996 Nov 19; 11(11):1784-92. PubMed ID: 8915787
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers of bone turnover during hormone replacement therapy.
    Masahashi T, Negoro Y, Kuroki T, Asai M, Noguchi M, Nakanishi M.
    Int J Gynaecol Obstet; 1999 Feb 19; 64(2):163-6. PubMed ID: 10189026
    [Abstract] [Full Text] [Related]

  • 17. Urinary galactosyl-hydroxylysine in postmenopausal osteoporotic women: A potential marker of bone fragility.
    Lo Cascio V, Bertoldo F, Gambaro G, Gasperi E, Furlan F, Colapietro F, Lo Cascio C, Campagnola M.
    J Bone Miner Res; 1999 Aug 19; 14(8):1420-4. PubMed ID: 10457275
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary deoxypyridinoline is a useful biochemical bone marker for the management of postmenopausal osteoporosis.
    Yu SL, Ho LM, Lim BC, Sim ML.
    Ann Acad Med Singap; 1998 Jul 19; 27(4):527-9. PubMed ID: 9791660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.